| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/26/2004 | EP1131050B1 Galenic formulations fast disintegrating in the mouth and method for preparing same |
| 05/26/2004 | EP1124815B1 Method for producing luteolin and luteolin derivatives |
| 05/26/2004 | EP1123110A4 Compositions and methods for promoting tissue repair using heat shock proteins |
| 05/26/2004 | EP1119359B1 2-methyl-thieno-benzodiazepine formulation |
| 05/26/2004 | EP1117661B1 Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof |
| 05/26/2004 | EP1117652B1 Tan-1057 derivatives |
| 05/26/2004 | EP1117642B1 Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use |
| 05/26/2004 | EP1115687B1 5,6-dihydronaphthalenyl derivatives having retinoid-like activity |
| 05/26/2004 | EP1104475B1 C-myc is activated by beta-catenin and tcf-4 |
| 05/26/2004 | EP1098873B1 Alpha-(2-hydroxyphenyl)nitrone compounds, pharmaceutical compositons containing the same and their use for treating inflammation |
| 05/26/2004 | EP1083927B1 HUMAN MINOR VAULT PROTEIN p193 |
| 05/26/2004 | EP1071398B1 Implants for administering substances and methods of producing implants |
| 05/26/2004 | EP1069885B1 Ophthalmic solution comprising glycogen |
| 05/26/2004 | EP1059941B1 Pharmaceutical compositions and their use |
| 05/26/2004 | EP1036083B1 Novel 9a-azalides |
| 05/26/2004 | EP1027332B1 Novel lactam metalloprotease inhibitors |
| 05/26/2004 | EP1023291B1 Dipyridoimidazolderivatives useful in treating central nervous system disorders |
| 05/26/2004 | EP1022272B1 Substituted fused heterocyclic compounds |
| 05/26/2004 | EP1015433B1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments |
| 05/26/2004 | EP1005445B1 N-alkanoylphenylalanine derivatives |
| 05/26/2004 | EP0971710B1 Use of chelerythrine and radiation for tumor therapy |
| 05/26/2004 | EP0971694B1 Drug preparations for treating sexual dysfunction |
| 05/26/2004 | EP0969851B1 Immunomodulatory complex and use thereof in helicobacter diseases |
| 05/26/2004 | EP0968194B1 Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists |
| 05/26/2004 | EP0929300B1 Cyanidin compositions and therapeutic and diagnostic uses therefor |
| 05/26/2004 | EP0915819B1 Illudin analogs useful as antitumor agents |
| 05/26/2004 | EP0894129B1 Short external guide sequences |
| 05/26/2004 | EP0888125B1 GLYCOSYLATED IgG ANTIBODIES |
| 05/26/2004 | EP0874819B1 Imides as pde iii, pde iv and tnf inhibitors |
| 05/26/2004 | EP0786253B1 Antitumor composition comprising ascorbic acid and metal complexes of (na)phthalocyanines |
| 05/26/2004 | EP0778768B1 Formulations and methods for providing prolonged local anesthesia |
| 05/26/2004 | EP0740650B1 Codrugs as a method of controlled drug delivery |
| 05/26/2004 | EP0676205B1 Cerebral metabolism activator containing glucose ester derivative |
| 05/26/2004 | EP0623346B1 Inhibitor for metastasis of malignant tumor |
| 05/26/2004 | EP0561977B1 Use of angiotensin ii receptor antagonists in the treatment of hemorragic stroke |
| 05/26/2004 | CN1500152A Nucleic acid vaccines for prevention of flavivirus infection |
| 05/26/2004 | CN1500147A Improved gene expression |
| 05/26/2004 | CN1500090A Beta-carboline derivatives and its pharmaceutical use against depression and anxiety |
| 05/26/2004 | CN1500089A Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain |
| 05/26/2004 | CN1500087A 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors |
| 05/26/2004 | CN1500086A Aminopiperidine derivatives |
| 05/26/2004 | CN1500085A Lipid lowering biphenylcarboxamides |
| 05/26/2004 | CN1500082A Cyano-5ubstituted dihydropyrimidine compounds and their use to treat diseases |
| 05/26/2004 | CN1500081A Thiohydantonins and use thereof for treating diabetes |
| 05/26/2004 | CN1500078A Aryl oxime-piperazines useful as CCR5 antagonists |
| 05/26/2004 | CN1499985A Articles comprising mint odor-free cooling agent |
| 05/26/2004 | CN1499976A Caloporoside derivatives, methods for prodn. thereof and their use |
| 05/26/2004 | CN1499975A Food item increasing cognitive capacity |
| 05/26/2004 | CN1499974A Remedies for vesical stimulation in association with prostatauxe |
| 05/26/2004 | CN1499973A Crystalline isoxazole derivative and medical prepn. thereof |
| 05/26/2004 | CN1499972A Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 05/26/2004 | CN1499971A Novel use of arylethene sulfonamide derivative |
| 05/26/2004 | CN1499970A Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods |
| 05/26/2004 | CN1499969A pharmaceutical formulation contg. pyrazolo[4,3-D] pyrimidine and nitrates or thienopyrimidines and nitrates |
| 05/26/2004 | CN1499968A Method of treatment of dopamine-related dysfuction |
| 05/26/2004 | CN1499967A Kappa opiate agonists for treatment of bladder diseases |
| 05/26/2004 | CN1499966A Compsn of norcantharidin with anticancer drugs containing platinum and its usage |
| 05/26/2004 | CN1499965A Bone metabolism improving agents |
| 05/26/2004 | CN1499964A Irrigating fluid |
| 05/26/2004 | CN1499963A Parasiticidal compsns. and methods of use |
| 05/26/2004 | CN1499962A Adhesive patch |
| 05/26/2004 | CN1499960A Chornotherapeutic dosage forms |
| 05/26/2004 | CN1499959A Pharmaceutical compsn. comprising poorly water-soluble active ingredient, surfactant and water-soluble polymer |
| 05/26/2004 | CN1499958A Medical aerosol formulations |
| 05/26/2004 | CN1499936A Mixtures of fructose and lactose as low-calorie bulk sweetener with reduced glycemic index |
| 05/26/2004 | CN1499930A Antifungal compsn. with enhanced bioavailability |
| 05/26/2004 | CN1499929A Formulations comprising entrapped active ingredients and uses thereof |
| 05/26/2004 | CN1498895A Artificial composite deoxygenation oligonucleotide with CpG single chain being contained, and effect of anti SARS virus |
| 05/26/2004 | CN1498889A Salt of gambogicacid class compound, its preparation method, and medication combination with salt as active ingredient |
| 05/26/2004 | CN1498659A Nutritious supplementing agent contg. a-glucosidase inhibitor and a-amylase inhibitor |
| 05/26/2004 | CN1498652A Compsn. for health care of teeth and curing oral disease |
| 05/26/2004 | CN1498626A Application of hyaluronic acid in raising immunity of human body and improving symptom of lacking immunity |
| 05/26/2004 | CN1498625A Application of basil polysaccharide for preparing medicine for curing tumour tranferring |
| 05/26/2004 | CN1498624A Puerarin gelation for eye use and prepn. method |
| 05/26/2004 | CN1498623A Glycyrrhizic acid and its derivative used as RANTES inducer |
| 05/26/2004 | CN1498622A Neurotoxicity inhibiting compsns. contg. ginsenoside Rg3 or ginsenoside Rh2 transferring glu |
| 05/26/2004 | CN1498621A Application of ginsenoside Re for preparing medicine for curing dysmnesia |
| 05/26/2004 | CN1498620A Compsn. containing oligose |
| 05/26/2004 | CN1498619A Hydrochloric 'Azasiqiong' tablet and its preparing method |
| 05/26/2004 | CN1498618A Injection of hydrochloric 'Azasiqiong' powder and its prepn. method |
| 05/26/2004 | CN1498617A Preparation containing Cetirizine Hydrochloride and hydrochloric pseudoephedrine and its prepn. method |
| 05/26/2004 | CN1498616A Compsns. for lowering cholesterol |
| 05/26/2004 | CN1498615A Preparation made from effective position of red sage root, and its prepn. method |
| 05/26/2004 | CN1498614A Camphor spraying agent as well as its producing method and product |
| 05/26/2004 | CN1498613A Combination of 5-HT3 receptor antagonist of spraying administration for treating nasal mucosa |
| 05/26/2004 | CN1498612A Medicament form of tatin class |
| 05/26/2004 | CN1498527A Method for producing breed of paddy capable of decreasing blood pressure |
| 05/26/2004 | CN1151377C Method of diagnosing and treating epithelioma |
| 05/26/2004 | CN1151253C Mycose base hydrolase and its preparation and use |
| 05/26/2004 | CN1151169C Novel antitumor compound philinopside B from striped pseudo-manatee |
| 05/26/2004 | CN1151168C Antisense thio-oligonucleic acid of target protein kinase C-alpha and its medicine composition and application in treating cancer |
| 05/26/2004 | CN1151167C Purine derivatives |
| 05/26/2004 | CN1151165C Macrolides with anti-inflammatory activity |
| 05/26/2004 | CN1151164C Prepn. of epimedium general flavone with osteoporosis resisting function |
| 05/26/2004 | CN1151161C Medicine nitrate salts |
| 05/26/2004 | CN1151156C Novel xanthone compounds, their preparation and use as medicament |
| 05/26/2004 | CN1151155C 1,5-dihydro-pyrazolo [3,4-D]-pyrimidinone derivatives |
| 05/26/2004 | CN1151152C New polycyclicazindole compound, its preparation method are medicine composition containing same |
| 05/26/2004 | CN1151151C Method for producing f-methoxy-quinoline carboxylic acids |
| 05/26/2004 | CN1151149C Substituted bisindolyl maleimides for inhibition of cell proliferation |